DHEA: Desire and resistance;La DHEA: Désir et résistance

Gynecologie Obstetrique et Fertilite

Volumn 30, Issue 12, 2002, Pages 961-969

  Belaisch, J ^a  

^a NONE   (France)

Author keywords

DHEA; Erectile dysfunction; Hormono dependent cancers; Intracrinolog; Libido; Prohomone

Indexed keywords

ANDROGEN; ESTROGEN; PRASTERONE;

AGING; BRAIN FUNCTION; COGNITION; CONFERENCE PAPER; ERECTILE DYSFUNCTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE RESISTANCE; HORMONE SYNTHESIS; HUMAN; LIBIDO; WELLBEING;

EID: 0036941508     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/S1297-9589(02)00490-3     Document Type: Conference Paper

References (30)

1. Young J, Schaison G. DHEA: Mythes et réalités. Reprod Hum Horm 2001;14:263-8.
2. Parker R. Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging. Steroids 1999;64:640-7.
3. Katz S, Morales AJ. DHEA and DHEAs as therapeutic options in menopause. Seminars in Reproductive Endocrinology 1998;16: 161-70.
4. Labrie F, Diamond P, Cusan L, et al. Effects of 12-month DHEA replacement therapy on bone, vagina and endometrium in post menopausal women. J Clin Endocrinol Metab 1997;82:3498-505.
5. Svec F, Porter R. The actions of exogenous dehydroepiandrosterone in experimental animals and humans, cet article comporte une bibliographie exhaustive de 137 références. P.S.B.M. 1998;218: 174-91.
6. Beaulieu E. Editorial DHEA: A fountain of youth? J Clin Endocrinol Metab 1996;81:3147-51.
7. Beaulieu E, Thomas G, Legrain S, Forette F. DHEA, DHEA sulfate, and aging: Contribution to the DHEAge study to a sociobiomedical issue. Proc Nal Acad Science USA 2000;97:4279-84.
8. Stomati M, Rubino S, Spinetti A, Genazzani AR. Endocrine neuro endocrine & beahavioral effect of oral DHEAs supplementation in postmenopausal women. Gynecol Endocrinol 1999;13:15-25.
9. Barnhart KT, Freeman E, Grisso JE, Nestler J. The effect of DHEA supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters and health related quality of life. J Clin Endocrinol Metab 1999;84:3896-902.
10. Casson PR, Santoro N, Elkind Hirsch K, Buster JE. Postmenopausal administration increases free insulin-like growth factor I and decreases high-density lipoproteine: A six-month trial. Fertil Steril 1998;70:107-10.
11. Arlt W, Callies F, Van Vlimjen JC, Allolio B. DHEA replacement in women with adrenal insufficiency. N Engl J. Med 1999;341: 1013-20.
12. Herman M, Berger P. Hormonal changes in aging men: A therapeutic indication? Exp Gerontol Jul 2001;36(7):1075-82.
13. Reiter WJ, Sycha A, Schatzl G, Pokorny A, Marberger M. DHEA in the treatment of erectile dysfunction: a prospective, double blind, randomized, placebo controlled study. Urology 1999;53:590-5.
14. Reiter WJ, Pycha A, Schatzl G, Klinger HC, Mark I, Auterith A, Marberger M. Serum dehydroepiandrosterone sulfate concentrations in men with erectile dysfunction. Urology May 2000;55(5):755-8.
15. Reiter WJ, Schatzl G, Mark I, Zeiner A, Pycha A, Marberger M. Dehydroepiandrosterone in the treatment of erectile dysfunction in patients with different organic etiologies. Urol Res Aug 2001;29(4): 278-81.
16. Barret Connor E, Goodman Gruen D. The epidemiology of DHEAs and cardiovascular disease. Ann New York Acad Sci 1995;774: 259-70.
17. Johannes CB, Stellato RK, Feldman HA, Longcope CH, McKinlay JB. Relation of DHEA and DHEA s with cardiovascular disease risk factors in Women: Longitudinal results from the Massachussetts women health study. J Clin Epidemiol 1999;52:95-103.
18. Nestler JE, Barlascini CO, Clore JN, Blackard WG. DHEA reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 1988; 66:57-61.
19. Morales AJ, Nolan JJ, Nelson JC, Yen SCC. Effects of replacement dose of DHEA in men and women of advancving age. J Clin Endocrinol Metab 1994;78:1360-7.
20. Calabrese VP, Isaacs ER, Regelson W. Dehydroepiandrosterone in multiple sclerosis: Positive effects on the fatigue syndrome in a non randomized study. In: Kalimi M, Regelson W, editors. The biologic role of dehydroepiandrosterone (DHEA). New York: Walter de Gruyter; 1990. p. 95-100.
21. Wolf OT, Neuman O, Hellhammer DH, Kirschbaum C. Effects of a two-week physiological DHEA substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab 1997;82:2363-7.
22. Barret Connort E, Edenstein SL. A prospective study of DS and cognitive function in an older population The Rancho Bernardo aging study. J Am Geriatr Soc 1994;42:420-3.
23. Morales AJ, Haubricht RH, Wangt J, Yen SS. The effect of 6 month treatment with a 100mg daily dose of DHEA on ciculating sex steroids, body composition and muscle strength in âge advanced men and women. Clinical Endocrinol 1998;49:421-32.
24. Khorram O, Vu L, Yen SSC. Activation of immune function by DHEA in age-advanced men. J Gerontol 1997;52 A:MI-7.
25. Dyne TS, Lang W, Geaga J, et al. An opel-label dose-escalation trial of oral DHEA tolerance and pharmacokinetics in patients with HIV disease. J. Acquir Immune Defic Syndr Hum Retrovirol 1993;6: 459-65.
26. Labrie F, Luu-The V, Labrie C, Simard J. DHEA and its transformation into androgens and estrogens in peripheral target tissues: Intracrinology. Front Neuroendocrinol Jul 2001;22(3):185-212.
27. Schmitt M, Klinga K, Schnarr B, Morfin R, Mayer D. Dehydroepiandrosterone stimulates proliferation and gene expression in MCF-7 cells after conversion to estradiol. Mol Cell Endocrinol 2001;173(1-2):1-13.
28. Morris KT, Toth-Fejel S, Schmidt J, Fletcher WS, Pommier RF. High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: A renewed role for adrenalectomy. Surgery Dec 2001;130(6):947-53.
29. Nieschlag E, Behre HM. Andrology, Male Reproductive Health and Dysfunction. Berlin: 2nd Springer; 2000.
30. Comhaire F. Andropause: Hormone replacement therapy in the ageing male. Eur Urol 2000;38:655-62.